Stylianos Georgiadis

Environmental sustainable decision making– The need and obstacles for integration of LCA into decision analysis

Yan Dong, Simona Miraglia, Stefano Manzo et al. · Environmental Science & Policy · 2018 · 89 citations · Full text

Business, Environmental Management, Environmental Policy +13

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

Brigitte Michelsen, Ulf Lindström, Cătălin Codreanu et al. · RMD Open · 2020 · 61 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Brigitte Michelsen, Stylianos Georgiadis, Daniela Di Giuseppe et al. · Arthritis Care & Research · 2021 · 43 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial

Hafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft et al. · Annals of the Rheumatic Diseases · 2021 · 33 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Lykke Midtbøll Ørnbjerg, Louise Linde, Stylianos Georgiadis et al. · Seminars in Arthritis and Rheumatism · 2022 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16